SEARCH

SEARCH BY CITATION

References

  • 1
    Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007; 4:5026.
  • 2
    Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005; 294:12559.
  • 3
    Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000; 160:16839.
  • 4
    Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5 Pt 1):141822.
  • 5
    Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57:84752.
  • 6
    Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005; 60:92531.
  • 7
    Donaldson GC, Wedzicha JA. COPD exacerbations: Epidemiology. Thorax. 2006; 61:1648.
  • 8
    Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance--United States, 1971–2000. MMWR Surveill Summ. 2002; 51:116.
  • 9
    American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995; 152(5 Pt 2):S77121.
  • 10
    Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163:125676.
  • 11
    Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176:53255.
  • 12
    Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23:93246.
  • 13
    Bach PB, Brown C, Gelfand SE, McCrory DC. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med. 2001; 134:60020.
  • 14
    Snow V, Lascher S, Mottur-Pilson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001; 134:5959.
  • 15
    Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007; 147:6338.
  • 16
    Wilt TJ, Niewoehner D, MacDonald R, Kane RL. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med. 2007; 147:63953.
  • 17
    Cydulka RK, Rowe BH, Clark S, Emerman CL, Camargo CA Jr. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: the Multicenter Airway Research Collaboration. J Am Geriatr Soc. 2003; 51:90816.
  • 18
    McCaig L, McLemore T. Plan and operation of the National Hospital Ambulatory Medical Survey. Vital Health Stat. 1994; 34:178.
  • 19
    Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007; (386):132.
  • 20
    Department of Health and Human Services. The international classification of diseases, 9th rev., clinical modification: ICD-9-CM. 5th ed. Vol.1. Washington, DC: Government Printing Office, 1994.
  • 21
    United States Bureau of the Census. Homepage. Available at: http://www.census.gov. Accessed Jun 18, 2008.
  • 22
    Schneider D, Appleton L, McLemore T. A reason for visit classification for ambulatory care. Vital Health Stat 2. 1979; (78):163.
  • 23
    US Food and Drug Administration. National Drug Code Directory, 1995 Edition. Washington, DC: Public Health Service, 1995.
  • 24
    Global Initiative for Chronic Obstructive Lung Disease (GOLD). NHLBI/WHO Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: http://www.goldcopd.org. Accessed Sep 11, 2008.
  • 25
    National Committee on Quality Assurance. The Health Care Effectiveness Data and Information Sets (HEDIS), 2008 Quality Measures for Pharmacotherapy of COPD Exacerbation. Available at: http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2008/2008_Measures.pdf. Accessed Jun 18, 2008.
  • 26
    Barr RG, Rowe BH, Camargo CA. Methylxanthines for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2003; (2):CD002168.
  • 27
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19:33551.
  • 28
    Scott S, Walker P, Calverley PM. COPD exacerbations. 4: Prevention. Thorax. 2006; 61:4407.
  • 29
    Tsai CL, Griswold SK, Clark S, Camargo CA Jr. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med. 2007; 22:799804.
  • 30
    Institute of Medicine. Committee on the Future of Emergency Care in the US Health System. The future of emergency care in the United States health system. Washington, DC: National Academy Press, 2006.
  • 31
    Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999; 354:45660.
  • 32
    Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med. 1999; 340:19417.
  • 33
    Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med. 1996; 1:40712.
  • 34
    Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003; 348:261825.
  • 35
    Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006; 130:184450.
  • 36
    Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006; 144:894903.
  • 37
    Institute of Medicine. Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
  • 38
    Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in U.S. hospitals as reflected by standardized measures, 2002–2004. N Engl J Med. 2005; 353:25564.